申请人:Thomas Craig J.
公开号:US20120245141A1
公开(公告)日:2012-09-27
Disclosed are pyruvate kinase M2 activators, which are, bis sulfonamide piperazinyl compounds of Formula (I) and 2,4-disubstituted 4H-thieno[3,2-b]pyrrole-2-(substituted benzyl)pyridazin-3(2H)ones of Formula (II), wherein L and R
1
to R
16
are as defined herein, that are useful in treating a number of diseases that are treatable by the activation of PKM2, for example, cancer and anemia,
本发明涉及丙酮酸激酶M2激活剂,其为式(I)的双磺酰胺哌嗪化合物和式(II)的2,4-二取代4H-噻吩[3,2-b]吡咯-2-(取代苄基)吡啶并[3(2H)]酮,其中L和R1至R16如本文所定义,可用于治疗许多可通过激活PKM2治疗的疾病,例如癌症和贫血。